{"id":"https://openalex.org/W2902717147","doi":"https://doi.org/10.2147/dmso.s184767","title":"Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1\u20133 fibrosis","display_name":"Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1\u20133 fibrosis","alternate_titles":[],"publication_year":2018,"publication_date":"2018-11-01","ids":{"openalex":"https://openalex.org/W2902717147","doi":"https://doi.org/10.2147/dmso.s184767","mag":"2902717147","pmid":"https://pubmed.ncbi.nlm.nih.gov/30568471","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6267487"},"language":"en","primary_location":{"id":"doi:10.2147/dmso.s184767","doi":"https://doi.org/10.2147/dmso.s184767","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s184767","pdf_url":"https://www.dovepress.com/getfile.php?fileID=46552","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2902717147"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=46552","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069773803","display_name":"Yuya Seko","orcid":"https://orcid.org/0000-0002-3658-5894","observed_orcids":["https://orcid.org/0000-0002-3658-5894"]},"institutions":[{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yuya Seko","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp","institution_ids":["https://openalex.org/I40677808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025337379","display_name":"Taichiro Nishikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Taichiro Nishikawa","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp","institution_ids":["https://openalex.org/I40677808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035273306","display_name":"Atsushi Umemura","orcid":"https://orcid.org/0000-0002-7433-8501","observed_orcids":["https://orcid.org/0000-0002-7433-8501"]},"institutions":[{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Atsushi Umemura","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp","institution_ids":["https://openalex.org/I40677808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087454705","display_name":"Kanji Yamaguchi","orcid":"https://orcid.org/0000-0002-0631-046X","observed_orcids":["https://orcid.org/0000-0002-0631-046X"]},"institutions":[{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kanji Yamaguchi","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp","institution_ids":["https://openalex.org/I40677808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004973697","display_name":"Michihisa Moriguchi","orcid":"https://orcid.org/0000-0001-9779-4369","observed_orcids":["https://orcid.org/0000-0001-9779-4369"]},"institutions":[{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michihisa Moriguchi","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp","institution_ids":["https://openalex.org/I40677808"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110056797","display_name":"Kohichiroh Yasui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kohichiroh Yasui","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp","institution_ids":["https://openalex.org/I40677808"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mayumi Kimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mayumi Kimura","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080530287","display_name":"Hiroaki Iijima","orcid":"https://orcid.org/0000-0003-4621-2394","observed_orcids":["https://orcid.org/0000-0003-4621-2394"]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hiroaki Iijima","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan"],"raw_orcid":"https://orcid.org/0000-0003-4621-2394","affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101135337","display_name":"Toshio Hashimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Toshio Hashimoto","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041533806","display_name":"Yoshio Sumida","orcid":"https://orcid.org/0000-0002-4342-1361","observed_orcids":["https://orcid.org/0000-0002-4342-1361"]},"institutions":[{"id":"https://openalex.org/I16528096","display_name":"Aichi Medical University","ror":"https://ror.org/02h6cs343","country_code":"JP","type":"education","lineage":["https://openalex.org/I16528096"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshio Sumida","raw_affiliation_strings":["Division of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University, Aichi, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University, Aichi, Japan","institution_ids":["https://openalex.org/I16528096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017078328","display_name":"Takeshi Okanoue","orcid":"https://orcid.org/0000-0002-2390-3400","observed_orcids":["https://orcid.org/0000-0002-2390-3400"]},"institutions":[{"id":"https://openalex.org/I4210125884","display_name":"Saiseikai Suita Hospital","ror":"https://ror.org/03ehcbt32","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210125884"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Takeshi Okanoue","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Osaka, Japan","institution_ids":["https://openalex.org/I4210125884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038459903","display_name":"Yoshito Itoh","orcid":"https://orcid.org/0000-0001-9890-3635","observed_orcids":["https://orcid.org/0000-0001-9890-3635"]},"institutions":[{"id":"https://openalex.org/I40677808","display_name":"Kyoto Prefectural University of Medicine","ror":"https://ror.org/028vxwa22","country_code":"JP","type":"education","lineage":["https://openalex.org/I40677808","https://openalex.org/I4405285717"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yoshito Itoh","raw_affiliation_strings":["Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan, taichi@koto.kpu-m.ac.jp","institution_ids":["https://openalex.org/I40677808"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5025337379"],"corresponding_institution_ids":["https://openalex.org/I40677808"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":6.4484,"has_fulltext":true,"cited_by_count":84,"citation_normalized_percentile":{"value":0.97694429,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"Volume 11","issue":null,"first_page":"835","last_page":"843"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.9678000211715698,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.026900000870227814,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/canagliflozin","display_name":"canagliflozin","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8939999938011169},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":1.0},{"id":"https://openalex.org/keywords/non-alcoholic-fatty-liver-disease","display_name":"non-alcoholic fatty liver disease","score":0.9309999942779541},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.8949999809265137},{"id":"https://openalex.org/keywords/alanine-aminotransferase","display_name":"alanine aminotransferase","score":0.9810000061988831},{"id":"https://openalex.org/keywords/liver-function-markers","display_name":"liver function markers","score":0.7269999980926514},{"id":"https://openalex.org/keywords/fib-4-index","display_name":"FIB-4","score":0.8569999933242798},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7509999871253967},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.6959999799728394},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9330000281333923}],"concepts":[{"id":"https://openalex.org/C2777451236","wikidata":"https://www.wikidata.org/wiki/Q5030940","display_name":"Canagliflozin","level":4,"score":0.8366103768348694},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7329601049423218},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.708638072013855},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.7026747465133667},{"id":"https://openalex.org/C2777766500","wikidata":"https://www.wikidata.org/wiki/Q360841","display_name":"Liver biopsy","level":3,"score":0.6699662804603577},{"id":"https://openalex.org/C2776954865","wikidata":"https://www.wikidata.org/wiki/Q1546498","display_name":"Nonalcoholic fatty liver disease","level":4,"score":0.6669430732727051},{"id":"https://openalex.org/C2992208098","wikidata":"https://www.wikidata.org/wiki/Q1359801","display_name":"Liver function","level":2,"score":0.5699150562286377},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.5450582504272461},{"id":"https://openalex.org/C2779478299","wikidata":"https://www.wikidata.org/wiki/Q2335423","display_name":"Steatohepatitis","level":4,"score":0.5132179260253906},{"id":"https://openalex.org/C512861765","wikidata":"https://www.wikidata.org/wiki/Q1359801","display_name":"Liver function tests","level":2,"score":0.5019972324371338},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.46864980459213257},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.43147867918014526},{"id":"https://openalex.org/C2993667909","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Hepatic fibrosis","level":3,"score":0.42963501811027527},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.428910493850708},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.39803507924079895},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.37817156314849854},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3318036198616028},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.13861355185508728}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.2147/dmso.s184767","doi":"https://doi.org/10.2147/dmso.s184767","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s184767","pdf_url":"https://www.dovepress.com/getfile.php?fileID=46552","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5268188","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6267487","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6267487","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6267487/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Metab Syndr Obes","raw_type":"Text"},{"id":"pmid:30568471","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30568471","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, metabolic syndrome and obesity : targets and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:dovepress.com/42644","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/efficacy-and-safety-of-canagliflozin-in-type-2-diabetes-mellitus-patie-peer-reviewed-article-DMSO","pdf_url":"http://www.mhlw.go.jp/file/06-Seisakujouhou-10600000-Daijinkanboukouseikagakuka/0000080278.pdf","source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:bfba1e10d95f4001b5ead934038fdfe6","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/bfba1e10d95f4001b5ead934038fdfe6","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity, Vol Volume 11, Pp 835-843 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.2147/dmso.s184767","doi":"https://doi.org/10.2147/dmso.s184767","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s184767","pdf_url":"https://www.dovepress.com/getfile.php?fileID=46552","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320327566","display_name":"Mitsubishi Tanabe Pharma Corporation","ror":"https://ror.org/038ehsm73"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2902717147.pdf","grobid_xml":"https://content.openalex.org/works/W2902717147.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W90736706","https://openalex.org/W1622799587","https://openalex.org/W1623910198","https://openalex.org/W1962594542","https://openalex.org/W1966200051","https://openalex.org/W1967972402","https://openalex.org/W2035962070","https://openalex.org/W2054305537","https://openalex.org/W2064890337","https://openalex.org/W2087829753","https://openalex.org/W2110875907","https://openalex.org/W2146264128","https://openalex.org/W2151369664","https://openalex.org/W2176459589","https://openalex.org/W2204688218","https://openalex.org/W2293932895","https://openalex.org/W2297835124","https://openalex.org/W2339363440","https://openalex.org/W2567512854","https://openalex.org/W2581381136","https://openalex.org/W2586108119","https://openalex.org/W2591859981","https://openalex.org/W2623457521","https://openalex.org/W2626446274","https://openalex.org/W2726939337","https://openalex.org/W2732773839","https://openalex.org/W2737083386","https://openalex.org/W2742155329","https://openalex.org/W2761135733","https://openalex.org/W2790286202","https://openalex.org/W2804715956","https://openalex.org/W2808615577","https://openalex.org/W2832998054","https://openalex.org/W2884837248","https://openalex.org/W3023974234","https://openalex.org/W4211155688","https://openalex.org/W4248089788"],"related_works":["https://openalex.org/W7168153901","https://openalex.org/W2765826121","https://openalex.org/W2982602066","https://openalex.org/W2795222338","https://openalex.org/W3178643921","https://openalex.org/W2527017295","https://openalex.org/W3162141249","https://openalex.org/W2900924712","https://openalex.org/W2912523003","https://openalex.org/W2810610880"],"abstract_inverted_index":{"AIM:":[0],"Nonalcoholic":[1],"fatty":[2],"liver":[3,107,144],"disease":[4],"(NAFLD),":[5],"including":[6,71,172],"nonalcoholic":[7],"steatohepatitis":[8],"(NASH),":[9],"is":[10,231],"known":[11],"to":[12,30,53,137,211],"be":[13,212,243],"associated":[14],"with":[15,42,63,93,99,237,251],"type":[16],"2":[17,33],"diabetes":[18],"mellitus":[19],"(T2DM)":[20],"in":[21,26,39,60,90,129,155,193,214,220,235,255],"high":[22],"rate.":[23],"The":[24,123],"improvement":[25],"hepatic":[27,74,88,157],"function":[28,89],"due":[29],"sodium-glucose":[31],"co-transporter":[32],"(SGLT2)":[34],"inhibitors":[35,59],"has":[36],"been":[37,78],"reported":[38],"T2DM":[40,61,91,97,238,249],"patients":[41,62,92,98,236,250],"and":[43,66,112,149,166,169,175,199,233,239],"without":[44],"NAFLD.":[45],"However,":[46],"only":[47],"a":[48,118],"few":[49],"studies":[50,70],"have":[51,77],"attempted":[52],"evaluate":[54],"the":[55,72,83,205,215,221,246],"role":[56],"of":[57,85,207,248,258],"SGLT2":[58],"biopsy-proven":[64],"NASH,":[65,252],"no":[67],"detailed":[68],"prospective":[69],"individual":[73,189],"fibrosis":[75,102],"stage":[76,103,197,200,216,222],"reported.":[79,187],"Therefore,":[80],"we":[81],"investigated":[82],"effect":[84,209],"canagliflozin":[86,114,230],"on":[87],"biopsy-confirmed":[94],"NASH.":[95,240,259],"METHODS:":[96],"NASH":[100],"(hepatic":[101],"1-3":[104],"confirmed":[105],"via":[106],"biopsy,":[108],"n=10)":[109],"were":[110,143,178,186,203],"enrolled":[111],"received":[113],"(100":[115],"mg)":[116],"once":[117],"day":[119],"for":[120,245],"12":[121],"weeks.":[122],"primary":[124],"end":[125,141],"point":[126],"was":[127],"change":[128],"serum":[130],"alanine":[131],"aminotransferase":[132],"(ALT)":[133],"levels":[134],"from":[135],"baseline":[136],"week":[138],"12.":[139],"Secondary":[140],"points":[142],"function/fibrosis":[145,158],"markers,":[146,159],"metabolic":[147,170],"parameters,":[148],"safety.":[150],"RESULTS:":[151],"=0.0526).":[152],"Significant":[153],"improvements":[154],"several":[156],"such":[160],"as":[161],"aspartate":[162],"aminotransferase,":[163],"fibrosis-4":[164],"index,":[165,168],"FM-fibro":[167],"parameters":[171],"hemoglobin":[173],"A1c":[174],"body":[176],"weight":[177],"found.":[179],"No":[180],"serious":[181],"or":[182],"liver-related":[183],"adverse":[184],"events":[185],"Regarding":[188],"patients,":[190],"different":[191],"trends":[192],"ALT-lowering":[194,208],"effects":[195],"between":[196],"1":[198,217],"2/3":[201,223],"subjects":[202],"observed;":[204],"degree":[206],"tended":[210],"greater":[213],"group":[218],"than":[219],"group.":[224],"CONCLUSION:":[225],"Our":[226],"results":[227],"suggest":[228],"that":[229],"effective":[232],"well-tolerated":[234],"Canagliflozin":[241],"may":[242],"useful":[244],"treatment":[247],"especially":[253],"those":[254],"early":[256],"stages":[257]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2902717147","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":24},{"year":2019,"cited_by_count":15}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-12-11T00:00:00"}
